Financial Survey: Pluri (NASDAQ:PLUR) & Passage Bio (NASDAQ:PASG)
Pluri (NASDAQ:PLUR – Get Free Report) and Passage Bio (NASDAQ:PASG – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability. Profitability This table compares Pluri and Passage Bio’s […]
More Stories
Trump Meets With Zelenskyy, Says He ‘Learned a Lot’ but His Viewpoint Is Unchanged
By Jackson Richman Former President Donald Trump met with Ukrainian President Volodymyr Zelenskyy on Sept. 27 as the GOP presidential...
Lebanon crisis: Guterres urges parties to ‘step back from the brink’
UN Secretary-General António Guterres expressed grave concern on Saturday over the dramatic escalation of events in Lebanon's capital, Beirut, over...
Bank of Communications Co., Ltd. (OTCMKTS:BCMXY) Sees Significant Drop in Short Interest
Bank of Communications Co., Ltd. (OTCMKTS:BCMXY – Get Free Report) saw a large decline in short interest in September. As...
Ukraine: UN official deplores deadly double attack on hospital
The top UN aid official in Ukraine has condemned Russian attacks in the northeastern city of Sumy on Saturday which...
CEMEX, S.A.B. de C.V. (NYSE:CX) Receives Average Rating of “Moderate Buy” from Analysts
Shares of CEMEX, S.A.B. de C.V. (NYSE:CX – Get Free Report) have been assigned an average recommendation of “Moderate Buy”...
Shell plc (NYSE:SHEL) Given Average Rating of “Moderate Buy” by Brokerages
Shell plc (NYSE:SHEL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven brokerages that...